A trial to investigate the effect of acalabrutinib on skin prick test wheal size in adults with grass pollen allergy
Phase 1
- Conditions
- grass pollen allergyTherapeutic area: Diseases [C] - Immune System Diseases [C20]
- Registration Number
- CTIS2023-505783-11-00
- Lead Sponsor
- Alk-Abello A/S
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 12
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method